(1)
BarnaM.; UomoI.; PastorelloM. Oral Agents for Treatment of Patients With Advanced Pancreatic Neuroendocrine Tumors: Could Pharmaeconomic, Cost-Effectiveness Data Play a Significant Role?. JOP 2013, 14, 102-104.